Epigallocatechin-3 gallate prevents pressure overload-induced heart failure by up-regulating SERCA2a via histone acetylation modification in mice

Molecular understanding of Epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases

(2018) Qian Yi Eng et al.   JOURNAL OF ETHNOPHARMACOLOGY

Molecular Defects in Cardiac Myofilament Ca2+-Regulation Due to Cardiomyopathy-Linked Mutations Can Be Reversed by Small Molecules Binding to Troponin

(2018) Alice Sheehan et al.   Frontiers in Physiology

Epigallocatechin gallate reverses cTnI-low expression-induced age-related heart diastolic dysfunction through histone acetylation modification

(2017) Bo Pan et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Potential role of green tea catechins in the management of oxidative stress-associated infertility

(2017) Shubhadeep Roychoudhury et al.   REPRODUCTIVE BIOMEDICINE ONLINE

Epidemiology and aetiology of heart failure

(2016) Boback Ziaeian et al.   Nature Reviews Cardiology

The Current and Future Landscape of SERCA Gene Therapy for Heart Failure: A Clinical Perspective

(2015) Carl Hayward et al.   HUMAN GENE THERAPY

Epigallocatechin-3-gallate (EGCG) as a pro-osteogenic agent to enhance osteogenic differentiation of mesenchymal stem cells from human bone marrow: an in vitro study

(2014) Pan Jin et al.   CELL AND TISSUE RESEARCH

Epigenetic Switch at Atp2a2 and Myh7 Gene Promoters in Pressure Overload-Induced Heart Failure

(2014) Tiziana Angrisano et al.   PLoS One

Cardiac SERCA2A/B: Therapeutic targets for heart failure

(2013) Mohammad Abrar Shareef et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

EGCG inhibits CTGF expression via blocking NF-κB activation in cardiac fibroblast

(2012) Yi Cai et al.   PHYTOMEDICINE

(-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells

(2011) V. Nandakumar et al.   CARCINOGENESIS

The Progression of Hypertensive Heart Disease

(2011) Mark H. Drazner   CIRCULATION

Green tea (−)-epigallocatechin-3-gallate inhibits HGF-induced progression in oral cavity cancer through suppression of HGF/c-Met

(2011) Yoon Woo Koh et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Synergistic epigenetic reactivation of estrogen receptor-alpha (ERalpha) by combined green tea polyphenol and histone deacetylase inhibitor in ERalpha-negative breast cancer cells

(2010) Yuanyuan Li et al.   Molecular Cancer

Beneficial effects of green tea: A literature review

(2010) Sabu M Chacko et al.   Chinese Medicine

Heart failure

(2009) Henry Krum et al.   LANCET

(−)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells

(2008) Young Chang Lim et al.   CANCER LETTERS

EGCG Inhibits Proliferation of Cardiac Fibroblasts in Rats with Cardiac Hypertrophy

(2008) Rui Sheng et al.   PLANTA MEDICA